OGRD Alliance Advances PLPC Multi-Asset Platform Following APHELAR Milestone, Expanding Licensing and Strategic Capital Frameworks
DUBAI, UAE, October 6th, 2026, FinanceWire Microdomain Science connects differentiated assets across personalized immuno-oncology, acellular biotechnology, MedTech and precision nutrition as OGRD Alliance expands international market access, asset-specific licensing, commercialization and strategic-capital initiatives. OGRD Alliance L.L.C-FZ announced a new phase in the international development of PLPC Platform following the public listing with Singapore’s Health Sciences Authority (HSA) of the APHELAR Family as Class A medical devices, with OGRD Alliance identified as Product Owner. The milestone adds a defined MedTech pathway to PLPC Platform, extending a broader multi-asset architecture designed to…
Read More